A detailed history of Regentatlantic Capital LLC transactions in Alcon Inc stock. As of the latest transaction made, Regentatlantic Capital LLC holds 8,133 shares of ALC stock, worth $694,395. This represents 0.01% of its overall portfolio holdings.

Number of Shares
8,133
Previous 8,798 7.56%
Holding current value
$694,395
Previous $615,000 23.09%
% of portfolio
0.01%
Previous 0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$56.96 - $78.09 $37,878 - $51,929
-665 Reduced 7.56%
8,133 $473,000
Q2 2022

Aug 15, 2022

BUY
$64.25 - $81.25 $2,056 - $2,600
32 Added 0.37%
8,798 $615,000
Q1 2022

May 02, 2022

BUY
$71.65 - $87.13 $14,616 - $17,774
204 Added 2.38%
8,766 $695,000
Q4 2021

Jan 27, 2022

BUY
$77.91 - $88.5 $10,284 - $11,682
132 Added 1.57%
8,562 $746,000
Q3 2021

Nov 15, 2021

SELL
$68.18 - $87.25 $3,749 - $4,798
-55 Reduced 0.65%
8,430 $678,000
Q2 2021

Aug 12, 2021

SELL
$66.27 - $76.21 $8,548 - $9,831
-129 Reduced 1.5%
8,485 $596,000
Q1 2021

Apr 29, 2021

BUY
$65.32 - $76.01 $280,092 - $325,930
4,288 Added 99.12%
8,614 $605,000
Q4 2020

Feb 04, 2021

BUY
$56.82 - $66.57 $1,363 - $1,597
24 Added 0.56%
4,326 $285,000
Q3 2020

Oct 13, 2020

SELL
$55.23 - $62.39 $8,615 - $9,732
-156 Reduced 3.5%
4,302 $245,000
Q2 2020

Aug 13, 2020

BUY
$49.45 - $64.16 $4,499 - $5,838
91 Added 2.08%
4,458 $256,000
Q1 2020

May 14, 2020

BUY
$39.86 - $63.46 $174,068 - $277,129
4,367 New
4,367 $222,000
Q4 2019

Feb 04, 2020

SELL
$55.04 - $59.27 $218,563 - $235,361
-3,971 Closed
0 $0
Q3 2019

Oct 22, 2019

SELL
$58.2 - $62.42 $28,227 - $30,273
-485 Reduced 10.88%
3,971 $231,000
Q2 2019

Jul 23, 2019

BUY
$54.43 - $63.33 $242,540 - $282,198
4,456 New
4,456 $276,000

Others Institutions Holding ALC

About ALCON INC


  • Ticker ALC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 490,087,008
  • Market Cap $41.8B
  • Description
  • Alcon Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgi...
More about ALC
Track This Portfolio

Track Regentatlantic Capital LLC Portfolio

Follow Regentatlantic Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Regentatlantic Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Regentatlantic Capital LLC with notifications on news.